Seamless integration of dose-response screening and flow chemistry: efficient generation of structure-activity relationship data of β-secretase (BACE1) inhibitors.

Drug discovery is a multifaceted endeavor encompassing as its core element the generation of structure-activity relationship (SAR) data by repeated chemical synthesis and biological testing of tailored molecules. Herein, we report on the development of a flow-based biochemical assay and its seamless integration into a fully automated system comprising flow chemical synthesis, purification and in-line quantification of compound concentration. This novel synthesis-screening platform enables to obtain SAR data on b-secretase (BACE1) inhibitors at an unprecedented cycle time of only 1 h instead of several days. Full integration and automation of industrial processes have always led to productivity gains and cost reductions, and this work demonstrates how applying these concepts to SAR generation may lead to a more efficient drug discovery process.

[1]  A. Manz,et al.  Revisiting lab-on-a-chip technology for drug discovery , 2012, Nature Reviews Drug Discovery.

[2]  Flavien Susanne,et al.  Continuous flow synthesis. A pharma perspective. , 2012, Journal of medicinal chemistry.

[3]  Elizabeth Farrant,et al.  Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery. , 2013, ACS medicinal chemistry letters.

[4]  Elizabeth Farrant,et al.  Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform. , 2013, Journal of medicinal chemistry.

[5]  Leslie Y Yeo,et al.  Microfluidic devices for bioapplications. , 2011, Small.

[6]  Klavs F. Jensen,et al.  The role of flow in green chemistry and engineering , 2013 .

[7]  Steven V. Ley,et al.  The flow synthesis of heterocycles for natural product and medicinal chemistry applications , 2011, Molecular Diversity.

[8]  F. Pammolli,et al.  The productivity crisis in pharmaceutical R&D , 2011, Nature Reviews Drug Discovery.

[9]  Q. Fang,et al.  Droplet-based microfluidic flow injection system with large-scale concentration gradient by a single nanoliter-scale injection for enzyme inhibition assay. , 2012, Analytical chemistry.

[10]  D. Schlatter,et al.  Substrate and Inhibitor Profile of BACE (β-Secretase) and Comparison with Other Mammalian Aspartic Proteases* , 2002, The Journal of Biological Chemistry.

[11]  Volker Hessel,et al.  Novel process windows for enabling, accelerating, and uplifting flow chemistry. , 2013, ChemSusChem.

[12]  O. Orwar,et al.  Microfluidic gradient-generating device for pharmacological profiling. , 2005, Analytical chemistry.

[13]  N. Allbritton,et al.  Micro total analysis systems for cell biology and biochemical assays. , 2012, Analytical chemistry.

[14]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[15]  Paul Watts,et al.  Continuous-flow organic synthesis: a tool for the modern medicinal chemist. , 2009, Future medicinal chemistry.

[16]  M. Bunnage.  Getting pharmaceutical R&D back on target. , 2011, Nature chemical biology.

[17]  Andrew J deMello,et al.  Micro- and nanofluidic systems for high-throughput biological screening. , 2009, Drug discovery today.

[18]  G. Taylor.  Dispersion of soluble matter in solvent flowing slowly through a tube , 1953, Proceedings of the Royal Society of London. Series A. Mathematical and Physical Sciences.

[19]  Hans-Joachim Böhm,et al.  A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.

[20]  Adam T. Melvin,et al.  Micro total analysis systems: fundamental advances and applications in the laboratory, clinic, and field. , 2013, Analytical chemistry.

[21]  A. Griffiths,et al.  High-resolution dose–response screening using droplet-based microfluidics , 2011, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Ian R. Baxendale,et al.  The integration of flow reactors into synthetic organic chemistry , 2013 .

[23]  Steven V. Ley,et al.  Flow chemistry synthesis of zolpidem, alpidem and other GABAA agonists and their biological evaluation through the use of in-line frontal affinity chromatography , 2013 .

[24]  W. R. Kelly,et al.  Determination of picogram quantities of Uranium in biological tissues by isotope dilution thermal ionization mass spectrometry with ion counting detection. , 1983, Analytical chemistry.

[25]  Sindy K. Y. Tang,et al.  Characterization of sensitivity and specificity in leaky droplet-based assays. , 2012, Lab on a chip.

[26]  Mickael Montembault,et al.  Leveraging the Advantages Offered by Microfluidics to Enhance the Drug Discovery Process , 2005 .

[27]  Wolfgang Guba,et al.  β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease. , 2013, Journal of medicinal chemistry.